Publication | Closed Access

Artificial neural network modeling enhances risk stratification and can reduce downstream testing for patients with suspected acute coronary syndromes, negative cardiac biomarkers, and normal ECGs

Enhances Risk StratificationHealth InformaticsCardiovascular DiseaseCoronary UnitNegative Cardiac BiomarkersPublic HealthCardiologyArtificial Neural NetworkEpidemiologyCoronary Artery DiseaseAcute Myocardial InfarctionMyocardial Infarction